Is OTLK undervalued or overvalued?

As of 2025-03-22, the Intrinsic Value of Outlook Therapeutics Inc (OTLK) is -7.31 USD. This OTLK valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.51 USD, the upside of Outlook Therapeutics Inc is -584.08%. This means that OTLK is overvalued by 584.08%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-7.31 - -7.31	-7.31	-584.08%
P/E	(31.20) - (45.03)	(39.36)	-2706.8%
DDM - Stable	(9.15) - (57.33)	(33.24)	-2301.3%
DDM - Multi	(9.68) - (52.20)	(16.86)	-1216.7%